Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2002 2
2003 1
2004 1
2005 1
2006 2
2007 1
2008 1
2009 1
2011 1
2012 3
2013 3
2014 1
2015 9
2016 15
2017 16
2018 15
2019 13
2020 12
2021 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31638455

86 results

Results by year

Filters applied: . Clear all
Page 1
Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.
Zafonte RD, Fregni F, Bergin MJG, Goldstein R, Boudreau N, Monge I, Luz M, Frazier J, Giacino JT. Zafonte RD, et al. Brain Inj. 2020;34(1):34-41. doi: 10.1080/02699052.2019.1677941. Epub 2019 Oct 22. Brain Inj. 2020. PMID: 31638455 Clinical Trial.
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial.
Brawman-Mintzer O, Tang XC, Bizien M, Harvey PD, Horner MD, Arciniegas DB, Raskind M, Johnson-Greene L, Martineau RJ, Hamner M, Rodriguez-Suarez M, Jorge RE, McGarity S, Wortzel HS, Wei Y, Sindowski T, Mintzer J, Kindy AZ, Donovan K, Reda D. Brawman-Mintzer O, et al. J Neurotrauma. 2021 Jul 15;38(14):1943-1952. doi: 10.1089/neu.2020.7146. Epub 2021 Mar 8. J Neurotrauma. 2021. PMID: 33514274 Clinical Trial.
Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury.
Meshkat S, Mahmoodi Baram S, Rajaei S, Mohammadian F, Kouhestani E, Amirzargar N, Tafakhori A, Shafiee S, Meshkat M, Balenci L, Kiss A, Riazi A, Salimi A, Aghamollaii V, Salmani F, Karima S. Meshkat S, et al. Brain Inj. 2022 Mar 21;36(4):553-559. doi: 10.1080/02699052.2022.2059816. Epub 2022 Apr 6. Brain Inj. 2022. PMID: 35385330 Clinical Trial.
86 results